Skip To Main Content
Erlisa Bardhi on Muck Rack

Erlisa Bardhi

As seen in: Reproductive BioMedicine Online, Cancer Treatment Reviews, EJSO - European Journal of Surgical Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Erlisa

Contact Erlisa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

IS OVARIAN RESPONSE ASSOCIATED TO ADVERSE PERINATAL OUTCOMES IN GNRH ANTAGONIST IVF/ICSI CYCLES?

|
By Erlisa Bardhi, Universitair Ziekenhuis Brussel, Christophe Blockeel, Wilfried Cools
| Reproductive BioMedicine Online Verified
Highlights • ART pregnancies are characterized by an increased risk for complications • The number of collected oocytes is a potential surrogate of oocyte quality • The number of oocytes retrieved is not related to birth weight z-scores • Ovarian response is not related to adverse perinatal and obstetric outcomes Abstract Research Question Is there an association between ovarian response and perinatal outcomes?
Open in Who Shared Issue with article?

Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review

|
By Violante Di Donato, Erlisa Bardhi, Luca Tramontano, Filippo Maria Capomacchia
| EJSO - European Journal of Surgical Oncology Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Fig. 1 Search strategy and study selection. Abstract Introduction In ovarian cancer (OC), survival benefit in case of complete cytoreduction with absence of residual tumor has been clearly demonstrated; however, it often requires extensive surgery. Particularly, pancreatic resection during cytoreduction, may severely impact perioperative morbidity and mortality.
Open in Who Shared Issue with article?

Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials according to brca mutational status

|
By Federica Tomao, Erlisa Bardhi, Carolina Maria Sassu, Elena Biagioli
| Cancer Treatment Reviews Verified
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 2 Risk of bias graph Figure 3 PFS in: a. whole population b. BRCA1-2 germline mutated population c. BRCA1-2 somatic mutated population d. HRD positive population e. wild type population Highlights •New therapeutic strategies in OC have led to a patient-tailored medicine. •PARPis, as new agents, have improved the maintenance-therapy landscape in ROC.
Open in Who Shared Issue with article?
See all 4 articles